BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 28, 2014
View Archived Issues
Mezzion Pharma begins evaluation of udenafil in adolescents with single ventricle heart defects
Read More
First patient treated in phase I study of MVA-BN Brachyury in advanced cancer
Read More
Sumitomo Dainippon to invest in Remiges BioPharma Fund
Read More
Essentialis secures grant to advance DCCR in Prader-Willi syndrome
Read More
Novel agents for HIV infection patented by Gilead Sciences
Read More
Rich Pharmaceuticals hires CRO for help on lead compound RP-323
Read More
BioFire Diagnostics begins study of FilmArray Meningitis/Encephalitis Panel
Read More
Merck KGaA commits to Chinese growth market
Read More
Patrys updates on preclinical pipeline progress
Read More
Bristol-Myers Squibb and Ono form strategic anticancer alliance in Japan, South Korea and Taiwan
Read More
Gilead Sciences signs new agreement with Medicines Patent Pool for tenofovir alafenamide
Read More
World Hepatitis Day: Advances in combination treatments and immunotherapies for chronic disease
Read More
Novel PI3Kdelta and gamma inhibitors disclosed by Aurigene Discovery Technologies
Read More
FDA clears IND for phase I study of MGD-007 for colorectal cancer
Read More
Topline results from phase III trial of sorafenib plus capecitabine in advanced breast cancer
Read More
Bristol-Myers Squibb reveals highlights of second quarter 2014
Read More
Results presented on MVTT-based HIV vaccine development
Read More
Gilead Sciences designs new anti-HIV agents
Read More
Kalvista Pharmaceuticals discloses new plasma kallikrein inhibitors
Read More
Xellia Pharmaceutical patents novel polymyxin antibiotics
Read More
Phase II results presented for TB vaccine in HIV-infected adults
Read More
Assembly decides against further development of VEN-307
Read More
CHMP adopts positive opinion for Imbruvica in CLL and MCL
Read More
EMA committee recommends approval of Zydelig in CLL and follicular lymphoma
Read More
CHMP recommends extension of Ozurdex indication in diabetic macular edema
Read More